Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smart Nanovirus
Pune, Maharashtra, Indiasmartnanovirus.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Smart Nanovirus is a biotechnology company focused on developing a novel class of antiviral therapeutics designed to mimic human cell surfaces to trap and neutralize viruses. The company's platform utilizes thio-ether lipid-based nanomicelles that act as 'nanodecoys,' binding to viral glycoproteins and preventing the virus from entering host cells. By targeting the conserved binding mechanisms of viruses rather than specific genetic sequences, the technology aims to provide broad-spectrum efficacy and resistance to viral mutations. Their current research pipeline includes candidates for COVID-19, influenza, and various herpesviruses.
- Therapeutic areas
- Infectious Diseases
- Modalities
- NanoparticleAntiviral
- Industry
- Biotech
Beyond the preview
Go deeper on Smart Nanovirus.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Smart Nanovirus.